Healthcare & Pharmaceutical Market Intelligence
Senegal is a stable, import-driven pharmaceutical market strategically positioned on West Africa’s Atlantic coast. With Dakar’s strong maritime connectivity, established trade corridors, and regional regulatory alignment, the country serves as a potential gateway to 8 or more French-speaking West African markets.
18.5M+
Population (2024)
USD 284M
Pharma Imports (2024)
>90%
Imported Medicines
≈USD 300–350M
Pharma Market
≈60%
Male Factor Contribution
Senegal relies heavily on imported medicines with limited local production.
Key Market Indicators
≈USD 300–350M
Formal Pharmaceutical Market
USD 60–110M
Dietary Supplements (≈7–11% CAGR)
USD 25–55M
Fertility Market
<10%
Local Production
USD 284M Imports • USD 4.67M Exports
Male Infertility Clinical Profile • 357 Men Evaluated
73.1%
Abnormal semen analysis
31.9%
Oligoasthenozoospermia
21.6%
Azoospermia
81%
Primary infertility (Aristide Le Dantec University Hospital • Dakar • 2026)
10–13%
PCOS prevalence benchmark (~18% in urban clinical populations)
Sources: Aristide Le Dantec University Hospital, Dakar • Female factor 40–50% • Male factor ≈60% (recent Senegalese clinical literature) • Infertility affects ≈15% of couples • OEC (HS30) 2024 • WHO • World Bank
Key Growth Drivers
Delayed childbearing and urban lifestyle changes
Rising awareness of reproductive health
Increasing diagnosis of hormonal disorders (PCOS, etc.)
High prevalence of anemia & micronutrient deficiencies
Expansion of OTC retail pharmacies
Francophone pharmaceutical entry gateway to 8+ markets
>90% of medicines are imported: strong opportunities for international suppliers
Growing OTC & pharmacy retail access
Women's health & fertility portfolio opportunity
Rising urban middle class and preventive healthcare awareness
